ISCO — International Stem Cell Share News
0.000.00%
- $1.20m
- $3.37m
- $9.10m
Brief: International Stem Cell Corp posts positive interim clinical results for Parkinson's disease clinical trial
Brief: International Stem Cell to expand its revenue generating biomedical businesses
Brief: International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson's disease
Brief: International Stem Cell Q3 revenue falls 9 pct to $1.94 mln
Brief: International Stem Cell files for resale of up to 116.3 mln shares
EU's top court opens door to some stem cell patents (updated)
EU's top court opens door to some stem cell patents